Influence of medical conditions on the diagnostic accuracy of plasma p-tau217 and p-tau217/Aβ42 Article Early Access

International Collaboration

cited authors

  • Olvera-Rojas, Marcos; Sewell, Kelsey R.; Karikari, Thomas K.; Huang, Haiqing; Oberlin, Lauren E.; Zeng, Xuemei; Morris, Jill K.; Collins, Audrey M.; Drake, Jermon A.; Sutton, Bradley P.; Kramer, Arthur F.; Hillman, Charles H.; Vidoni, Eric D.; Burns, Jeffrey M.; Kamboh, M. Ilyas; Mcauley, Edward; Marsland, Anna L.; Chen, Yijun; Lafferty, Tara K.; Sehrawat, Anuradha; Jakicic, John M.; Wan, Lu; Kang, Chaeryon; Erickson, Kirk I.

Publication Date

  • December 6, 2024

webpage

published in

category

keywords

  • amyloid beta
  • blood-based biomarkers
  • cardiovascular
  • cognitively unimpaired
  • diabetes
  • medical conditions
  • p-tau